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The emergence and spread of antibiotic resistance is a growing global threat and has
aroused a global interest in limiting antibiotic use in animal agriculture. As we are entering
the post-antibiotic era, there is a growing need for identifying alternatives to antibiotics
for prevention and treatment. Although phytotherapeutic remedies are available and are
used in Europe, evidence of their efficacy is currently very limited but is nevertheless still
necessary. A systematic review of phytotherapy used for the treatment and prevention of
infectious diseases in farm animals has been conducted using the PICOS approach.
Analysis and extraction of information from studies was performed according to a
protocol, and included: publication year and source, research body, species, farming
system, purpose of application, disease in focus, diagnostic method, remedy used
(origin and ingredients of the remedy), producer of remedy, way of administration, study
design, and control groups, measure of effect, and outcome of the study. A total of
1,705 papers were screened, but only 44 (comprising 53 independent studies) met the
inclusion criteria. The majority of the scientific studies identified show limitations in the
study design as well as in presentation and standardization of the botanical remedies
studied, which limits the possibilities of drawing firm conclusions. Preventive effect was
investigated in 89% of the studies. Half of the studies reported uncertain effects of the
botanical remedies on subclinical measures in comparison to a control group. The review
highlights unresolved questions such as the need for standardized controlled trials and
for improved standardization of the botanical products by analytical methods, such as
high-performance liquid chromatography. It is necessary to consider this in order to
achieve replicable outcomes and establish efficacy and safety of phytotherapy in farm
practice. The manageability of alternative medicine in farm animals also warrants further
investigation so as to ascertain whether all necessary preconditions for their use are being
granted.
Keywords: PICOS approach, veterinary phytotherapy, botanical treatment, medicinal plants, efficacy evaluation,
antibiotic resistance, effectiveness
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INTRODUCTION
Since their advent in the last century, antibiotics have become
essential for the treatment of infectious diseases in both humans
and animals and have enormously improved the health of
the population as well as food security and safety. However,
studies have demonstrated that routine use of antibiotics may
lead to antimicrobial resistance, and the rapid development of
resistance has emerged as amajor global public and animal health
issue (1–3). Both antimicrobial resistance and a possible future
limitation on antibiotic use for animal agriculture could have an
impact on global food security and safety as well as on animal
health and welfare (4). As we are entering the post-antibiotic era,
there is a growing need to identify alternatives to antibiotics.
The antimicrobial activity of plant oils and extracts has been
recognized for many years (5). Over the last two decades, the
study of phytotherapy—modern scientific herbal medicine in
which the molecular interactions between plant components
and cells are studied to provide evidence-based treatments—
has gained strength in the scientific community (6–9). Despite
its promising potential for replacing antibiotic treatments (10)
research and reviews on the use of botanical products in animal
agriculture have mainly focused on alternatives to antibiotic
growth promoters or boosters of general health (11–13).
However, where the essence of treatment such as curative,
metaphylaxis, and prevention, the three different circumstances
for antimicrobial treatment, might has not been well formulated
and recognized in the case of alternative treatments (14).
On the market, the availability of veterinary herbal medicinal
products varies greatly among EU countries (15), and feed
additives available to farmers are heterogeneously used to
improve performance and general health with the main purpose
of prevention (16).
The aim of this study was to evaluate the current potential of
phytotherapeutic products for replacing antibiotics for treatment
and prevention (since prevention reduces the need to treat) of
specific diseases of cattle, poultry, and swine in Europe. This was
done by performing a systematic literature review according to
PRISMA guidelines of studies using phytotherapeutic remedies
and evaluating their study design and treatment efficacy.
MATERIALS AND METHODS
This review is part of a European Project (No. 311824)
called IMPRO (http://www.impro-dairy.eu/). The project aimed
to overcome weak points in current health management
strategies on organic dairy farms and addressed, for instance,
the assessment of the manageability of alternative treatments
according to the state-of-the-art for different farm animals.
Literature Search
The literature search was performed between 12th and 14th of
February 2014 in the databases Web of Science, Pubmed, and
Scopus according to PRISMA guidelines (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses) (17). PRISMA
guidelines provide an evidence-based minimum set of items
regarding the methodology and identification of publications as
well as reporting in these types of reviews. The search terms were
defined in collaboration with a professional librarian specialized
in scientific databases using the PICOS approach (population,
intervention, comparison, outcome, and study design), and
exclusion of terms was added to remove a large number
(>10,000) of off-topic publications. The final search terms were:
bovine OR cattle OR cow OR cows OR heifer OR heifers OR (dairy
AND calf) OR (dairy AND calve) OR (dairy AND calves) OR calve
OR calves OR calf OR calfs OR (dairy AND herd) OR (dairy AND
herds) OR (dairy AND farm) OR (dairy AND farms) OR swine
OR pig OR pigs OR piglet OR piglets OR weanlings OR weanling
OR weaner OR weaners OR fatteners OR fattener OR porcine OR
poultry OR hen OR hens OR laying hen OR chicken OR chickens
AND
((herbal OR herb) AND (medicine OR medicinal OR extract OR
treatment OR product OR tincture OR drug OR remedy OR
remedies OR supplement OR preparation)) OR phytotherapy OR
phytotherapeutic OR phytoceutic OR phytochemical OR phytogenic
OR phototherapeutic OR medicinal plant OR plant extract OR
ethnoveterinary medicine OR (bioactive AND (plant OR herb OR
drug)) OR essential oil OR organic acid OR genistein OR capsaicin
OR carotenoid OR saponin OR saponins OR tannin OR tannins OR
polyphenol OR polyphenols OR lignan OR lignins OR aromatic acid
OR glucosinolate OR glucosinolates OR thymol OR (natural AND
(terpene OR terpenes OR flavonoid OR flavonoids OR flavone)).
AND
comparison OR compared OR prevention OR preventive OR
treatment OR treatments OR treating OR ((control OR outbreak)
AND (disease OR infection OR diseases OR infections))
AND
(efficacy OR effectiveness OR effect OR efficiency OR capability OR
potency OR success OR ineffectiveness OR ineffective OR failure OR
inefficiency)
NOT
(vaccine OR vaccination OR “in vitro” OR mice OR rat OR “guinea
pig” OR “shelf life” OR filets OR “ground meat”)
The period of publications considered was from year 2000 until
the starting time of the search. The search and the filtering
process (Figure 1) were performed by the same person in order
to achieve consistency.
Inclusion and Exclusion Criteria
Studies in peer-reviewed scientific journals performed under
European conditions (with respect to housing, breed, and
intensive farming) where the effect of one or several substances
derived from plants were used as treatment or to prevent a
specific infection, production disease or symptom of disease
on cattle, poultry, or pigs. Studies where phytotherapeutic
substances were given with the aim of reducing shedding of
pathogens were included, as this use could have a preventive
effect on herd level.
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FIGURE 1 | Search process for identifying publications where phytotherapeutic remedies are used to treat/prevent disease.
Studies performed in conditions not comparable to European
animal husbandry with respect to breeds, housing, and farming
system were excluded as were studies published in journals that
did not supply information of a peer review process where
excluded from the review. In addition, studies of the treatment
effect on general or physiological parameters not associated
with a specific disease or specified clinical symptoms, such as
growth, general mortality by unspecified reason and changes in
microbiota or immune system were excluded from the review.
IDENTIFICATION OF LITERATURE FOR
REVIEW
Publications that included more than one experimental study
were extracted as separate studies for the evaluation and
comparison of data. Analysis and extraction of information
from studies was performed according to a protocol and
included: publication year and source, research body, species,
location/farming system, purpose of application, disease in focus,
diagnostic method, remedy used (origin and ingredients of the
remedy), producer of remedy, route of administration, study
design, and control groups, measure of effect, and outcome of the
study. A gold standard for presenting phytotherapeutic remedies
was acquired from “Authentication and quality assessment of
botanicals and botanical products used in clinical research”
in Evaluation of Herbal Medicinal Products in 2009. The
information extracted from eligible studies is fully presented
in Supplementary Material 1 (study design and outcomes) and
Supplementary Material 2 (phytotherapeutic treatments).
The use of the phytotherapeutic substance was classified as
a treatment or prophylactic. When substances were used on
animals with established disease, meaning clinical symptoms,
or other pathological changes detected by analytical diagnostic
methods, they were considered to be used as treatment. The
use was classified as prophylactic when the substance was given
to healthy animals before infection/disease contraction so as to
prevent or reduce the effect of a specific pathogen/pathogens
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or reduce the incidence of disease in a population. Studies
where experimental infection or other disease inductions were
performed on the same day as the phytotherapeutic remedy was
started were categorized as prophylactic studies because infection
or disease was not established on the day the treatment began.
According to the efficacy of the botanical remedies, studies
were sorted into four categories. Category A included remedies
that significantly reduced clinical signs (including body
temperature) and mortality. In category B were placed the
substances that caused significant positive effects on subclinical
measures in comparison to a control group. If the substance
gave small, not statistically significant differences or significant
differences that were not clearly associated with the disease
compared to control groups, the result was classified as uncertain
(category C). If no effect at all was reported, the study was
categorized as D.
RESULTS
The literature search gave a large number of publications
(n = 1,705), but throughout the review process most were
excluded as they did not fulfil the inclusion criteria (Figure 1).
Of the remaining 44 publications, 22 were performed on poultry,
14 on pigs, and eight on cattle. In total, these 44 publications
included 53 separate studies. The majority of the studies (89%)
investigated the preventive effect of phytotherapeutic products
against specific diseases, while only six studies, five in cattle,
and one in pigs, investigated the effect of treating an established
disease after diagnosis. Of the 53 studies 44 studies were
performed in a controlled experimental environment and nine
were performed in a farm conditions. Of the studies performed
on farms one studied poultry, four cattle, and four pigs.
The diseases studied in the publications are presented in
Figure 2. They were dominated by infectious diseases of a specific
pathogen (n = 44) or symptoms commonly caused by infectious
origin (n = 5). Four studies, all of subclinical or clinical ruminal
acidosis, were not associated with infectious disease.
Study Design
A schematic overview of the study designs for the 44
studies performed in controlled experimental conditions are
presented in Figure 3A and the nine studies performed in farm
environment are presented in Figure 3B. All studies except
one were randomized trials in which animals were randomly
assigned to different treatment and control groups. One study of
ruminal acidosis was a cross-over design with eight individuals
and a 15-day long transition period between treatments (18).
Blinding was only reported in five of the 53 identified studies
(19) (one study); (20) (four studies). In these specific surveys,
the blinding was done on a laboratory level where the person
interpreting pathological and histological changes did not know
which group the individual animals came from. The number of
animals included in the studies varied, but half of the studies
used fewer than 20 animals per treatment group. Two studies,
both performed in a commercial farm environment (21, 22)
included more than 100 animals per treatment group. No
power calculations regarding the number of treated animals were
presented in any of the studies.
Experimental Induction of Disease
The most common induction of disease was experimental
infection with a pathogenic organism or toxin derived
from a pathogenic organism (37 studies). For poultry, this
included all studies except one, and for pigs 10 out of 14
studies, respectively. Induction was not used in any of the
five studies of disorders associated with infectious origin
in cattle. Experimental induction was only used in one
study of pneumonia (23), but in this study induction was
not performed by infection with a pathogen; symptoms
of pneumonia were instead induced by administering
mineral oil to the lung through a tracheal catheter. In the
remaining studies, animals were infected naturally from their
environment.
The severity of disease and how the presence of disease
was measured varied between studies. Twenty-eight studies
reported no clinical signs, i.e., subclinical disease, and 11 studies
reported a low frequency of clinical signs indicating low level
of disease. In the 39 studies using experimental induction, 11
reported the use of a validated or a previously validated dose,
although in three of these no reference to the original study was
provided. For the remaining studies, re-isolation of the infectious
agent and/or specific histological or pathological changes were
common indicators of successful infection. However, in four of
the studies only unspecific measures, not related to the disease,
were used as both indicator of the disease and measure of
outcome. Of the 10 studies where spontaneous disease was
studied, five established disease by isolation of an infectious agent
or disease specific changes. In the remaining studies, clinical
symptoms or indirect measures were studied.
In general, the studies did not specify who performed the
diagnostic procedure except in one of the studies on dairy calves
by Oliveira et al. (24), where the research team performed the
diagnostic procedure. No information on whether the research
team contained veterinarians or other professions was given.
Large varieties of outcome-measures were studied. Some
studies included several outcomes directly and/or indirectly
linked to the disease while others reported only a few specific
outcome measures. The majority of the studies (n= 46) included
unspecific measurements indirectly associated with the disorder,
such as, for example, production parameters (body weight,
feed intake, and average daily gain) and mortality, in general
in combination with more specific outcomes associated with
the disease. Specific measures, such as rate of re-isolation of
the pathogen or specific histological, pathological, and clinical
changes for the disease in each individual treated, were used in
41 of the 53 studies. Nine of the remaining 12 studies did not
use specific measures and included animals with no or very low
levels of clinical symptoms, making the studies rely heavily on
indirect tests. The remaining three studies, all studying the effect
on Escherichia coli-induced diarrhea in calves or pigs, included
animals with clinical signs. In animals from those studies, E. coli
was isolated, but it remained unclear whether E. coli was the only
causative agent of the diarrhea.
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FIGURE 2 | Diseases studied in the 53 identified studies.
CONTROL GROUPS
On Farm Studies
For the studies performed in farm conditions, the most
common control group was a non-treated control group
which was included in seven out of nine studies. In three
of these an additional control group receiving an alternative
treatment was included. Two studies did not use any negative
control group (given no treatment or placebo) but compared
the effect of the botanical remedy with a control group
receiving an alternative therapy type. One study compared the
phytotherapeutic treatment with an injection of antibiotics on
diarrhea in dairy calves (25) and one compared the effect of
the phytotherapeutic treatment on endometritis cattle with one
group receiving local application of Lotagen and one group
receiving hormonal treatment with prostaglandins (26).
Controlled Environment
The combinations of control groups used in the studies
performed under controlled experimental conditions are
presented in Figure 4. It was very common to include a
challenged and untreated control group (included in 95% of the
studies). Placebo was not commonly used, but two studies on
cattle and one on poultry included this (27–29).
An unchallenged and untreated control group was included
in 79.5% of the studies. Of these, 18 studies (33%) were factorial
designs that also integrated a non-challenged group receiving the
botanical supplement. The inclusion of a control-group receiving
an additional treatment was also relatively common (45%).
Often, the choice was the conventional treatment normally used
in practice (for example, a coccidiostatic, antimicrobial drug, or
vaccination) (36%). However, there were also studies comparing
an alternative treatment (15%). These were, for example,
supplementing mannanoligosaccharide (n = 1), probiotics
(n = 3), calcium aminosilicate (1), formic acid (1), or a
combination of formic acid and copper (1).
Phytotherapeutic Treatments
The types of phytotherapeutic treatments used are presented in
Figure 5. Fifteen studies used commercial treatments available on
the market, including products derived from a single botanical
as well as botanical mixtures. Of the remaining 28 studies,
treatments were derived from a single botanical, although 14
of these included multiple treatment groups receiving different
doses. The remaining 10 studies investigated the effect of multiple
treatments of single botanicals as well as treatments of mixtures
of different botanicals. In total (including commercial products),
12 studies used supplements consisting of several plants. In two
of these, the separate effects of the included botanicals were also
studied. The majority of the treatments were administered at a
group level through feed (n = 44) or water (n = 2). Five studies
used individual oral administration. The remaining two used
parenteral and intrauterine administration.
The scientific names of the plants used were given in 34
studies. Sixteen additional studies reported a common name of
the plant or a processed plant-derived product. Three studies
did not provide any information about the original plant of the
naturally derived substance used. Instead, these studies (30–32)
reported the use of a purified active substance of natural origin.
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FIGURE 3 | (A) Study design of the 44 studies identified in the literature review that were performed on controlled experimental conditions. (B) Study design of the
nine studies identified in the literature review that were performed on farm conditions.
In total, the use of 12 commercial products was reported in 18
studies. In three of these studies, the commercial product was
mixed with an unknown combination of other botanicals.
The type of botanical preparation used varied and in three
cases is not stated at all. In eight studies, combinations or several
types of preparations were studied, commonly a dried herb
extract and an essential oil. Extracts (including dry extracts) were
used in 13 studies, essential oils in nine studies, powders and
dried ground botanical parts in nine studies. The specification of
content or composition of ingredients and dosage of the applied
botanicals in the studies reviewed was generally poor. In many
cases (37 studies), underlying information about processing,
apart from original plant and/or manufacturer, was not given.
Twenty studies reported the content of active markers, although
a description of the method for establishing this was lacking
in all but 11 studies. Full chemical characterization using state
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FIGURE 4 | Different types of control groups and the combinations included in the identified studies performed under controlled experimental conditions. Other
treatment includes allopathic remedies as well as non-botanical alternative remedies. All rows include a challenged group receiving the studied phytotherapeutic
remedy.
FIGURE 5 | Presentation of the phytotherapeutic remedies used in the 53 studies identified in the review.
of the art analytical method HPLC was carried out in four
studies.
Efficacy of the Remedies
Only one study reported no difference between the treated
group and the challenged control (category D). However, the
results of about half of the studies (n = 31) were categorized
as uncertain (category C). Seven of these were on cattle, 12
on poultry and 12 on pigs. The reason for this classification
varied. In 10 studies, no animals or only a small number
of animals showed clinical signs and/or the mortality was
very low, leading to questions of whether any of the animals
studied were in fact unhealthy. It is possible that they were
not affected by the same pathogen/condition, or that the
experimental infection was not successful. In four studies, non-
specific changes in blood, microflora, or production parameters
were discovered, but the importance of these changes on the
course of the disease was not clear. Two studies described
a reduction of the pathogen in the intestine, but in one of
these studies the effect on the clinical disease was not clear.
In the other, a large numerical reduction in the number of
pathogens was observed. However, no calculations of significance
were provided and the sample size was very small. Four
studies reported occasional small but significant differences
between the treated group and the control group. However, as
the significant differences noted were small and inconsistently
seen in occasional measurements across a large number of
measurements and measuring points, they were classified as
uncertain. Three studies observed confounding variables. In two
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studies, the animals were also vaccinated; leading to difficulties in
interpreting to what extent the botanical and the vaccine affected
the results.
In 10 studies (19%), the botanical treatment led to a significant
decrease in clinical signs or mortality (category A), and in 11
studies (21%) significant positive effects on subclinical measures
were noted (category B). In eight of these studies, the effectiveness
of the phytotherapeutic was compared to a control group
receiving conventional treatment. Of these studies, four were of
coccidiosis and the conventional treatment was a coccidiostatic.
The botanical treatments were in all cases less effective at
reducing lesions than the conventional treatment. Three of the
conventional treatments were antibiotics against Mycoplasma
gallisepticum (33) and a combination of coccidiosis and necrotic
enteritis [two studies from McDougald et al. (20)]. In these
studies, the botanical treatment was comparable to the antibiotic
treatment.
DISCUSSION
One approach to resolving contradictory study results is to
conduct systematic reviews and metanalyses of rigorous studies
(34). However, in the field of alternative medicines, systematic
reviews are helpful for sorting through conflicting evidence and
exposing the different challenges and limitation that have to be
addressed.
From the review, there are some key facts that have been
neglected in the study of the efficacy of phytotherapy. The
majority of the identified scientific studies showed limitations in
the study design of the trials as well as regarding presentation
and standardization of the botanical remedies studied. The
efficacy of alternative treatments should be scientifically proven
using an appropriate study design, particularly Randomized
Controlled Trials (RCTs) that are considered the gold standard
for estimating the true effect of an intervention. Evidence-
based recommendations are primarily related to the clinical
design. Undoubtedly, trials should be designed according to the
important guidelines/aspects of alternative medicine therapies
and frame in it into the definitions of either a veterinary
medicinal product or a feed additive, considering the possible
use of specific claims (14). But, as in studies of the association
of antibiotic exposure and antibiotic resistance, both are subject
to common obstacles including control group selection and
measures of outcomes (where there is probably a high variability
of factors affecting the outcome on the farm). Besides the study
design, the correlation structures of the different outcomes and
structural characteristics of the farm system in the outcome are
challenges for the epidemiological model building process. This
heterogeneity of the study design and outcome measures makes
them difficult to compare.
Although numerous studies have demonstrated efficacy
in vitro, respective experimental in vivo evidence is still
quite limited (35). No general statement about the efficacy of
phytotherapeutic products can be validated, as the studies in
the review were also lacking reproducibility. A fundamental
problem in the clinical research into herbal medicines is whether
different products, extracts, or even different lots of the same
extract are comparable and equivalent (36). Quality control of
botanicals poses significant challenges, as small differences in
genetics, soil, temperature, moisture, and time of harvesting can
lead to significant differences in the concentration of important
constituents (37). Only in a very few cases in the review was
the same botanical remedy used to treat the same condition in
multiple studies. Mostly, this was seen in publications containing
more than one study, but there were also some cases where
a similar compound was used in different studies by different
authors. For example, Dra˘gan et al. (29) and Dra˘gan et al. (38)
both present treatment with powder derived from Artemisia
annua but, as no description of the process, active markers or
manufacturer was given in Dra˘gan et al. (29), it was not possible
to establish the similarity of the botanical product. New analytical
methods may possibly be used to establish a “characteristic
chemical fingerprint” of chemical ratios that allows a control
of consistency between batches (39). These methods may also
increase the possibility of identifying contamination, like for
example heavy metals, pesticides, wrong plants, and synthetic
drugs, which are critical to ensure safe use of botanicals.
Standardization is also difficult for phytotherapeutic products,
as they are complex combinations of several phytochemicals.
If it is difficult to demonstrate appropriate activity for a single
product, it is more complicated with a combination. The specific
function of several phytochemicals as well as how they interact
with other molecules are still largely unknown, which makes
standardization difficult (40–42). In this way, pooling studies
that use different herbal products or qualities in a quantitative
metanalysis can be misleading (36).
Managing animal health on many farms can be done at
different levels of intervention. This approach does not exclude
the stringent high-quality research of phytotherapy in research
trials, but interventions with phytotherapy must be validated and
must be replicable with the overview of efficacy and safety in
the farm practice. To overcome obstacles, the need for improved
study designs for clinical trials was given priority on a workshop
of experts that addressed the current societal challenges of the
use of phytotherapy on livestock (43) in order to prove the
efficacy of remedies and to implement amonitoring systemwhich
enables the assessment of the effectiveness of treatments in farm
practice. From the review, no trials have been repeated under the
same or comparable conditions (with respect to species, remedy,
context/disease, and expertise). Current trials on efficacy were
conducted under standardized conditions and do not consider
the specific situation which farm animals experience without
accounting for the interaction between animals and their living
conditions and animals’ differing ability to react to certain
pathogens.
The knowledge of the essential prerequisites for ensuring a
therapeutic effect when treating farm animals under practical
conditions does not exist to a sufficient degree in any therapy
tool. The efficacy of any action to promote health on the farm,
including the use of herbal remedies, cannot be limited to
the concentration of pharmaceutical active ingredients alone
and cannot be isolated from the context in which it is used,
since it is highly farm context-variant. The appropriateness
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FIGURE 6 | Variability accumulated in the different components or actors when using phytotherapy in farm practice. This overview of variation accumulated from the
efficacy and effectiveness of phytotherapy could be converted into the prerequisites that are needed for the manageability of phytotherapy as a therapy tool.
of phytotherapy also depends to a high degree on the
appropriateness of initial and boundary conditions on the
farm and health management intervention. These conditions
are, however, not restricted to phytotherapy, but apply also to
conventional medicine and are not commonly met.
The effectiveness of treatments in farm practice is highly
context-dependent and depends on several extrinsic factors
(Figure 6). It is not possible to draw firm conclusions until
these essential preconditions for a target-oriented and effective
use of phytotherapeutic products are established. In the
case of phytotherapy, prerequisites include a knowledge of
ingredients, efficacy in relation to the dose and mechanisms
of action and interactions with other treatments (allopathic
or phytotherapeutic). There is also a need for expertise,
both to implement the treatment procedures necessary to
ensure therapeutic success as well as to provide a deeper
understanding of the cost-benefit outcome relationship where
positives outweigh negatives while keeping to a minimum
negative side effects that might compromise the issues of animal
health and welfare, food safety, and environmental impact as
common goods. These factors could be included in a critical
control points-approach (Control points tominimize the variable
effect of phytotherapy), since it fits preventive risk management
programs with the ultimate goal of increasing animal product
safety (one of the criticism against phytotherapy) and protecting
public health. A broader perspective when looking at options
for reducing the use of antibiotics in practice might set the
design of future trials where study applications of combined
interventions (different therapy tools) with a holistic and
sustainable approach considering the whole farm system are
involved.
RISK OF BIAS
Publication bias may exist, because studies with no identifiable
effects may be difficult to publish, which influences the
understanding of the scientific progress in the research area. This
is one of the major threats to validity in systematic reviews and
meta-analyses (44). The success of a systematic review depends
on the availability, accessibility, and quality of literature related
to the review question.
The pilot searches revealed a very large number of
publications although they were not particularly accurate because
they included publications that did not fit the purpose, while still
probably missing publications that fitted the inclusion criteria.
The review would have benefited from the recent opinion of
EFSA and EMA in terms of the standard vocabulary to establish
the including criteria (14). Studies were excluded from the review
of how phytotherapeutic remedies influence general parameters
such as growth, mortality, and other physiological changes
or effects on immune system and changes in microbiota not
associated with clinical symptoms.
CONCLUSION
The systematic review highlighted problems of inadequate
study design and lack of reproducibility of studies on
phytotherapeutic remedies. Based on the results of the review,
it is not currently possible to make definitive conclusions on
the effectiveness of phytotherapeutic treatments for diseases
in farm practice. This does not mean that there is no
potential future place for these treatments, and examples
of well-designed RCT studies using of modern tools for
standardization of the botanical products with positive effects
were identified. To gain further insights into the potential
use of phytotherapy and therapy success, these well-designed
studies also need to be combined with evaluation of effectiveness
under heterogeneous farm conditions. Against the background
of large number of side effects associated with conventional
antibiotic treatments, future studies should consider that the
most sustainable strategy for prevention and therapy may
combine viable alternative treatments and changes in farm
practice.
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